Netherlands Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Dutch Respiratory Devices Market is Segmented by Type (Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, and Other Diagnostic and Monitoring Devices), Therapeutic Devices (Ventilators, Inhalers, CPAP Devices, and Other Therapeutic Devices), and Disposables (Masks, Breathing Circuits, and Other Disposables). The report offers values in USD million for all the above-mentioned segments.

Netherlands Respiratory Devices Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
Netherlands Respiratory Devices Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2021 - 2022
CAGR 9.60 %

Major Players

Netherlands Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Netherlands Respiratory Devices Market Analysis

The Dutch respiratory devices market is expected to grow with a CAGR of 9.6% during the forecast period.

During the COVID-19 pandemic, the demand for major respiratory devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators increased due to the high number of COVID-19-infected patients in the country. With the increased severity of COVID-19 in the country, several companies increased their ventilator production to combat the pandemic. For instance, in April 2020, Medtronic ramped up the production of ventilators by more than 40%, increasing the capacity to make and supply the devices to hospitals globally. Also, in April 2020, the Philips Foundation partnered with Refugee Company and its feedstock supplier to provide a loan for two mask-making machines to alleviate the shortage of medical face masks in the Netherlands. This indicates the urgent need for respiratory devices like ventilators, oxygen concentrators, and nebulizers, especially for COVID-19 patients in the country. Moreover, with the released COVID-19 restrictions and resumed treatment and elective surgery procedures, the demand for respiratory devices is expected to increase over the forecast period.

Certain factors attributing to the market growth are the increasing prevalence of respiratory disorders and growing applications in home care settings.

In addition, the rising geriatric population, who are more prone to develop respiratory disorders due to their weak immunity, is also contributing to the market growth. For instance, according to the 2022 statistics published by the UNPF in the Netherlands, a large proportion of the living population was aged between 15 and 64, accounting for 64% in 2022. In addition, as per the same source, 21% of the population was aged 65 years and above in 2022.

The increasing burden of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), sleep apnea, and tuberculosis among the population is also expected to increase the market growth over the forecast period. For instance, as per GLOBOCAN 2020 factsheet, about 13,500 new lung cancer cases were reported in the Netherlands in 2020. Also, the increasing number of smokers in the country raises the risk of developing lung cancer and other respiratory problems, which, in turn, is expected to increase the demand for respiratory devices. For instance, as per the statistics published by Netherlands Expertise Center for Tobacco Control in June 2022, about 20.6% of adults aged 18 years and older in the Netherlands smoked in 2021. Thus, the rising prevalence of respiratory issues among the population is expected to increase the demand for ventilators and other respiratory devices, thereby propelling the market's growth.

Additionally, as per an article published in European Respiratory Journal in July 2021, it was found that the prevalence of chronic obstructive pulmonary disease (COPD) is anticipated to increase in Europe (including the Netherlands) due to rising risk factors like smoking and air pollution. Similarly, from an article published in PLOS One in November 2022, it was found that the frequency of COPD in patients with COVID-19 was the highest in the Netherlands at 17% in 2021. Thus, the expected increase in the number of people suffering from COPD in the country and the rising prevalence is expected to increase the demand for inhalers and nebulizers to deliver various COPD medications to patients, which, in turn, is anticipated to propel the demand for respiratory devices over the forecast period.

Furthermore, rising government initiatives are also contributing to the market's growth. For instance, in May 2021, the Netherlands shipped 449 ventilators, 100 oxygen concentrators, and other medical supplies to India to fight against the COVID-19 pandemic. This is anticipated to increase the company's focus on accelerating the production of ventilators and oxygen concentrators, thereby propelling the market's growth.

Therefore, owing to the aforementioned factors, the market studied is expected to grow over the forecast period. However, the high cost of devices such as ventilators and respiratory humidifier are likely to impede market growth during the forecast period.

Netherlands Respiratory Devices Market Trends

This section covers the major market trends shaping the Netherlands Respiratory Devices Market according to our research experts:

Ventilators Segment is Expected to Grow Over the Forecasted Period

The ventilator segment is expected to witness significant growth in the respiratory devices market during the forecast period, owing to the factors such as the rising prevalence of respiratory diseases, brain injuries, cardiac arrest, and strokes among the population.

A ventilator is an equipment that delivers mechanical ventilation by moving breathable air into and out of the lungs to deliver breaths to a patient who is unable or insufficiently breathing. Modern ventilators are microprocessor-controlled computers. However, patients can also be ventilated using a simple, hand-operated bag valve mask. Ventilators are most employed in intensive care, home care, emergency medicine, and anesthesiology. In addition, ventilators are used in the treatment of various respiratory diseases, and the growing prevalence of these diseases is expected to boost the segment's growth.

In addition, the increased number of COVID-19 infections among the population also increased the demand for ventilators in healthcare settings across the world, which, in turn, impacted the growth of the segment. For instance, an article published in the Nature Public Health Emergency Collection in February 2022 stated that the male population in the country was at high risk of mortality during the first three months of the outbreak in the Netherlands. Also, as per another article published in PLOS One in October 2021, it has been observed that moderate and severe traumatic brain injury cases were common in the elderly population and are the primary cause of death in people with severe trauma injuries. Thus, the high burden of brain injuries is also expected to increase the demand for ventilators over the forecast period, propelling the market's growth.

Furthermore, the companies increased their ventilator production to treat patients with respiratory insufficiency during the COVID-19 pandemic. For instance, Royal Philips doubled the production of its hospital ventilators in May 2020 and achieved a four-fold increase by the third quarter of 2020. Also, in April 2020, Philips introduced a new Philips Respironics E30 ventilator as a readily available ventilation alternative during the COVID-19 crisis in situations. Thus, such initiatives taken by the companies are expected to have a positive impact on the segment's growth.

Thus, owing to the aforementioned factors, such as the high burden of coronavirus infection, increasing prevalence of traumatic brain injury, and increasing product launches, the segment studied is expected to grow significantly during the forecast period.

Netherlands Respiratory Devices Market : Tuberculosis Cases (in Numbers), Netherlands, 2020-2021

Masks Segment is Expected to Have Significant Market Share Over the Forecast Period

The masks segment is expected to witness significant growth in the Dutch respiratory devices market during the forecast period. The factors attributing to the segment's growth are the increasing COVID-19 and tuberculosis infections, rising demand for masks to prevent the spread of infection, and growing company activities.

The number of patients suffering from tuberculosis has increased in the country, which is anticipated to raise the demand for respirators to protect against inhaled toxins, propelling the market's growth. For instance, according to the data published by ECDC, in March 2022, 680 people with tuberculosis (TB) were reported in the Netherlands in 2021 compared to 622 patients with TB in 2020. Thus, the high number of TB infections in patients is expected to increase the demand for surgical masks to prevent the inhalation and spread of airborne droplet nuclei, thereby boosting segment growth.

Additionally, different types of masks are used to prevent and treat respiratory diseases. For instance, venturi masks and nasal prongs masks are used to treat acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD).

Furthermore, the rising government initiatives to reduce the number of COVID-19 cases in the country are anticipated to fuel the segment's growth. For instance, in November 2021, the Dutch government reintroduced surgical masks to curb the spread of COVID-19 infection among the population in the Netherlands. This is expected to increase the demand for masks, boosting the segment's growth. 

Therefore, owing to the factors such as rising tuberculosis cases and growing government initiatives in the country, the segment studied is expected to grow over the forecast period.

Netherlands Respiratory Devices Market : Projected Population with Chronic Obstructive Pulmonary Disease (COPD) (%), Netherlands, 2021-2050

Netherlands Respiratory Devices Industry Overview

The Dutch respiratory devices market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players are DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, Getinge AB, and GlaxoSmithKline PLC.

Netherlands Respiratory Devices Market Leaders

  1. DeVilbiss Healthcare LLC

  2. Dragerwerk AG

  3. Fisher & Paykel Healthcare Ltd

  4. GE Healthcare

  5. Getinge AB

*Disclaimer: Major Players sorted in no particular order

Netherlands Respiratory Devices Market - cl.png
Need More Details on Market Players and Competitors?
Download PDF

Netherlands Respiratory Devices Market News

  • September 2022: Onera Health launched its ground-breaking solution, Onera Sleep Test System and the Onera Digital Health Platform, to diagnose sleep disorders. The company provides Onera's Polysomnography-as-a-Service solution in the Netherlands.
  • June 2021: Onera BV received a CE (Certificate of Conformity) for its patch-based home sleep testing system.

Netherlands Respiratory Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Respiratory Disorders
    • 4.2.2 Increasing Applications in Homecare Setting
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Devices
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Diagnostic and Monitoring Devices
    • 5.1.1.1 Spirometers
    • 5.1.1.2 Sleep Test Devices
    • 5.1.1.3 Peak Flow Meters
    • 5.1.1.4 Other Diagnostic and Monitoring Devices
    • 5.1.2 Therapeutic Devices
    • 5.1.2.1 Ventilators
    • 5.1.2.2 Inhalers
    • 5.1.2.3 CPAP Devices
    • 5.1.2.4 Other Therapeutic Devices
    • 5.1.3 Disposables
    • 5.1.3.1 Masks
    • 5.1.3.2 Breathing Circuits
    • 5.1.3.3 Other Disposables

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 DeVilbiss Healthcare LLC
    • 6.1.2 Dragerwerk AG
    • 6.1.3 Fisher & Paykel Healthcare Ltd
    • 6.1.4 GE Healthcare
    • 6.1.5 Getinge AB
    • 6.1.6 GlaxoSmithKline PLC
    • 6.1.7 Invacare Corporation
    • 6.1.8 Koninklijke Philips NV
    • 6.1.9 Medtronic PLC
    • 6.1.10 DEMCON Macawi Medical Systems BV
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Netherlands Respiratory Devices Industry Segmentation

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. 

The Dutch respiratory devices market is segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, and other diagnostic and monitoring devices), therapeutic devices (ventilators, inhalers, CPAP devices, and other therapeutic devices), and disposables (masks, breathing circuits, and other disposables). The report offers values in USD million for all the above-mentioned segments.

By Type Diagnostic and Monitoring Devices Spirometers
Sleep Test Devices
Peak Flow Meters
Other Diagnostic and Monitoring Devices
By Type Therapeutic Devices Ventilators
Inhalers
CPAP Devices
Other Therapeutic Devices
By Type Disposables Masks
Breathing Circuits
Other Disposables
Need A Different Region Or Segment?
Customize Now

Netherlands Respiratory Devices Market Research FAQs

The Netherlands Respiratory Devices Market is projected to register a CAGR of 9.60% during the forecast period (2024-2029)

DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare and Getinge AB are the major companies operating in the Netherlands Respiratory Devices Market.

The report covers the Netherlands Respiratory Devices Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Netherlands Respiratory Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Netherlands Respiratory Devices Industry Report

Statistics for the 2024 Netherlands Respiratory Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Netherlands Respiratory Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Netherlands Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)